SIBO (small intestinal bacterial overgrowth): the hidden metabolic driver behind IBS

📋 本文重點摘要

SIBO — bacterial overgrowth in the small intestine — produces bloating, IBS-like symptoms, and metabolic dysfunction through impaired absorption, increased intestinal permeability, and systemic inflammatory signaling. This article explains the mechanism and the dietary approaches with evidence.

📌 一句話答案
SIBO — bacterial overgrowth in the small intestine — produces bloating, IBS-like symptoms, and metabolic dysfunction thr…

Small intestinal bacterial overgrowth (SIBO) occurs when bacteria — normally concentrated in the large intestine — colonize the small intestine in excessive numbers, fermenting carbohydrates where absorption should be occurring and producing gas, toxins, and inflammatory signals that affect both gut function and systemic metabolism. SIBO is found in 30–85% of IBS patients (depending on diagnostic criteria) and in significant proportions of people with metabolic disease — suggesting it is both a consequence of and contributor to metabolic dysfunction.

How SIBO causes metabolic disruption

Bacterial fermentation in the small intestine (where it should not be occurring) produces gas (hydrogen, methane) that causes bloating and altered gut motility. More metabolically significant: bacterial products from SIBO damage the small intestinal brush border, impairing absorption of B vitamins (particularly B12 and folate), fat-soluble vitamins (D, E, K, A), and minerals. This malabsorption pattern creates micronutrient deficiencies that impair TCA cycle function, mitochondrial activity, and immune regulation. SIBO also increases small intestinal permeability, allowing bacterial products to enter the portal circulation and activate hepatic inflammation.

Dietary approaches for SIBO management

Low-fermentable carbohydrate diets (the low-FODMAP diet, or elemental diets in severe cases) reduce the substrate available for bacterial fermentation in the small intestine, reducing symptom burden while treatment is pursued. These diets are therapeutic tools for symptomatic management, not permanent dietary patterns — long-term FODMAP restriction reduces colonic microbiome diversity and should be carefully managed with professional guidance. CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides dietary consultation using CNFCD for clients with complex gut health presentations.


CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.

👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.

— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life

🌿

ResetWith 顧問團隊

CNFCD® 個人化代謝健康系統 | 微康公司

本文由 ResetWith 顧問團隊根據科學文獻與超過 16 萬筆台灣真實個案數據撰寫。所有內容以 CNFCD® 方法論為基礎,供健康參考使用。

發布:2026年6月3日 最後更新:2026年6月3日

⚠️ 免責聲明:本文內容僅供健康參考,不構成醫療建議、診斷或治療建議。CNFCD® 健康計劃屬飲食調整與生活型態顧問服務,非醫療行為,不取代醫師診斷。如有糖尿病、慢性腎病、心血管疾病等慢性病史,請先諮詢主治醫師後再考慮飲食調整。

Author, Review, and Health Content Note

Publisher: ResetWith consulting team. Principal consultant: Pangpang / Sean Shih. Last updated: 2026-06-03.

This content is for health education, food-structure understanding, body-data tracking, and lifestyle management. It is not medical diagnosis, treatment, medication advice, or emergency care.

Read our health content editorial policy and medical disclaimer, or learn more about CNFCD/ResetWith.

CNFCD
CNFCD 健康顧問
線上諮詢 · 即時回覆